Compare INTG & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INTG | IXHL |
|---|---|---|
| Founded | 1965 | 2001 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Building operators | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 63.3M |
| IPO Year | 1995 | 2024 |
| Metric | INTG | IXHL |
|---|---|---|
| Price | $41.04 | $3.57 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 13.6K | ★ 284.5K |
| Earning Date | 05-13-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.67 | N/A |
| Revenue | ★ $74,753,000.00 | $12,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $56.91 | ★ N/A |
| Revenue Growth | ★ 4.43 | N/A |
| 52 Week Low | $10.37 | $0.16 |
| 52 Week High | $43.84 | $6.39 |
| Indicator | INTG | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 60.18 | 41.68 |
| Support Level | $29.93 | $0.34 |
| Resistance Level | $42.48 | $3.68 |
| Average True Range (ATR) | 2.55 | 0.32 |
| MACD | -0.06 | -0.14 |
| Stochastic Oscillator | 74.43 | 2.68 |
The Intergroup Corp is a company operating in the real estate sector. It was formed to buy, develop, operate, rehabilitate, and dispose of real property of various types and descriptions, as well as to engage in other related business and investment activities. The company operates through three segments: Hotel, Real Estate, and Investment Transactions. The Hotel Operations segment, which generates the majority of the revenue, covers the operation of the Hilton hotel and garage. The Real Estate Operations segment involves the management of multifamily rental properties, while the Investment Transactions segment includes investments of cash in marketable securities and other assets.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.